GNS aims to help MDs know which treatment will work the best for each patient
When Colin Hill’s father was diagnosed with later-stage prostate cancer last summer, he was treated the same as every other patient with the illness.
This standardized approach bothered Hill, who believes medicine should approach each patient’s illness as unique, with medication tailored to the person’s history and biology.
“You show up to the hospital, and it’s like Groundhog Day,” Hill said, with patients being cared …
Harvard researchers have licensed GNS Healthcare’s REF (Reverse Engineering and Forward Simulation) Big Data analytics platform to build computational models of the mechanisms involved in cell differentiation in hopes of building better treatments.
Comprehend Systems and GNS Healthcare made progress with very different software tools for drug researchers. Yet both companies have lived up to FierceBiotech IT’s choice to include them in an October 2011 report on tech companies to watch in the biotech arena.
Tech entrepreneurs have been raving for a while now about big data changing the world, and it’s mostly bullshit. Venture capitalist Brad Feld made this point, more or less, when he was being purposely provocative at an Xconomy event last fall.
The announcement of a $100 million government research initiative to map the human brain has been compared to the human genome project and the Apollo space mission. Not only will it deepen our understanding of degenerative neurological conditions such as Alzheimer’s Disease and Parkinson’s Disease as well as traumatic brain injuries, but it will also impact other areas of science. That’s partly because to do the research that is required, new tools will need to be developed such as more …
If there was one constant in Silicon Valley over the last decade, it was the near steady, profitable growth of Oracle Corp. No longer.
Working with and making business decisions based on data is good for your company’s bottom line. Companies that have embraced a data-driven culture–rating themselves substantially ahead of their peers in their use of data–are three times more likely to rate themselves as substantially ahead of their peers in financial performance, according to findings by the Economist Intelligence Unit in a survey sponsored by Tableau Software.
Roughly 7.6 million people in the world die due to cancer every year, according to the Center for Disease Control. Biotechnologists in the Greater Boston area are working to change that.
GNS Healthcare has spent more than a decade refining computer analytics, with co-founder and CEO Colin Hill saying more than once that his company needs the right data to assemble models for personalized medicine.